Newsroom

Celdara Medical and C-Path’s Translational Therapeutics Accelerator Announce Pipeline-focused Partnership

TRxA-Celdara

LEBANON, N.H. and TUCSON, Ariz.– Celdara Medical and Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced the signing of a Memorandum of Understanding (MOU) aimed at identifying and advancing promising new therapeutics in areas of high unmet medical need. Under the terms of this agreement, both organizations look […]

Continue Reading

Celdara Medical Awarded SBIR Fast-Track Funding for Development of Cell Therapy for Amyotrophic Lateral Sclerosis

Lebanon, NH: The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) has awarded Celdara Medical a Fast-Track Small Business Innovation Research (SBIR) grant to fund the development of engineered regulatory T cells (Tregs) therapy for Amyotrophic Lateral Sclerosis (ALS). ALS is a debilitating […]

Continue Reading

Call for Applications: Celdara Medical High Potential Entrepreneurs’ Fellowship 2023-24

Fellowship Call for Applications

Celdara Medical seeks outstanding scientists with an interest in translational research and biotechnology for a paid Fellowship ($15/hour – remote optional). Prior Fellows have jumpstarted their careers in Venture Capital, Management Consulting, Technology Transfer, R&D, Medical Writing, and Business Development.​    Program Description​  1-year experiential learning to gain real-world experience in biotechnology​  Develop executive skills including […]

Continue Reading

Celdara Medical Awarded Phase II SBIR Funding to Develop Therapeutics for Pandemic-Potential Influenza Strains

Program NoAs Template 2023

Lebanon, NH: National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Innovation Research (SBIR) Fast-Track grant to Celdara Medical. This award supports the ongoing development of CM-IAV1, a promising therapeutic antibody designed to treat high-priority influenzas that […]

Continue Reading

Celdara Medical and University of Vermont Funded to Develop Therapeutic Antibodies for Hantavirus Cardiopulmonary Syndrome

Employee Highlight (3)

Lebanon, NH: National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Technology Transfer (STTR) grant to fund the ongoing development of therapeutic antibodies for the treatment of Hantavirus Cardiopulmonary Syndrome (HCPS). The funding will support the ongoing […]

Continue Reading

Scientist

Position Description Celdara Medical, LLC (CM) is building a portfolio of early-stage medical companies in collaboration with leading academicians. Each of these is at a different stage of development with a different development path. Celdara aims to bring these products to market with urgency. Our Mission is to give hope […]

Continue Reading

Celdara Medical and ARMI Partner to Accelerate Commercialization of Regional Biofabrication Technologies 

ARMI

Celdara Medical and ARMI Partner to Accelerate Commercialization of Regional Biofabrication Technologies  Lebanon, NH: Celdara Medical today announced a partnership with the Advanced Regenerative Manufacturing Institute (ARMI) to support and advise ARMI’s newly-created BioFab Startup Lab and its portfolio companies.  The BioFab Startup Lab includes companies that are developing medical […]

Continue Reading

Enquire now

Give us a call or fill in the form below and we'll contact you. We endeavor to answer all inquiries within 24 hours on business days.